9 METERS BIOPHARMA, INC. INNT Income Statement

9 meters biopharma, inc. (INNT)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Sep'15	Jun'15
Net sales
-	-	-	-	-	-	-	-	-	-	-	-	-	4,065	0	0	0	0	0
Cost of goods sold
-	-	-	-	-	-	-	-	-	-	-	-	-	3,329	0	0	0	0	0
Gross profit (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	736	0	0	0	0	0
Operating expenses:
Research and development
15,116	13,715	9,958	4,229	2,399	7,559	6,990	9,143	9,030	4,007	2,934	2,621	1,556	270	0	0	0	0	0
Selling and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	2,425	0	0	0	0	0
General and administrative
9,122	10,566	10,724	9,725	8,808	10,664	9,715	10,123	9,551	7,161	6,580	6,458	5,572	3,984	0	0	0	0	0
Warrant inducement expense
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
26,195	25,548	20,682	13,955	11,208	18,224	16,706	19,267	18,581	11,169	10,163	10,279	8,919	6,679	0	0	0	0	0
Loss from operations
26,195	25,548	20,682	13,955	11,208	18,224	16,706	19,267	18,581	11,169	7,898	3,194	-397	-5,943	0	0	0	0	0
Other income (expense):
Interest income
171	185	193	177	159	163	0	0	0	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-
Interest expense
1,970	1,825	1,889	2,455	2,917	6,152	5,748	4,820	4,026	436	490	405	644	825	0	0	0	0	0
Gain of settlement of customer refund
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-
Gain (Loss) on Extinguishment of Debt
0	-1,049	-1,049	-1,049	-1,049	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative liability and extinguishment of derivative liability
1,110	1,243	931	702	521	50	0	0	0	-	-	-	-	-	-	-	-	-	-
Fair Value Adjustment of Warrants
-667	54	-141	-2,669	-857	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Gain on debt conversion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	-
Total other income (expense), net
-21	-1,500	-1,672	45	-2,429	-5,938	-5,620	-4,735	-3,995	-436	0	0	0	-	-	-	-	-	-
Total other (income) expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Debt conversion expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Total other expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Total other expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Loss before income taxes
-26,217	-27,048	-22,355	-13,909	-13,637	-24,162	-22,327	-24,002	-22,577	-11,605	-10,487	-9,868	-8,317	-6,211	0	0	0	0	0
Benefit from income taxes
0	0	0	0	0	0	0	0	0	0	0	2	2	2	0	0	0	0	0
Net Income (Loss) Attributable to Parent
-26,217	-27,048	-22,355	-13,909	-13,637	-24,162	-22,327	-24,002	-22,577	-11,605	-10,487	-9,870	-8,319	-6,213	0	0	0	0	0
Net loss per common share, basic and diluted (in usd per share)
-0.09	-0.26	-0.26	-0.13	-0.16	-0.09	-0.03	-0.16	-0.70	-0.33	-0.08	-0.23	-0.34	-11.16	-0.27	-0.33	0.50	0.45	0.38
Weighted-average common shares, basic and diluted (in shares)
41,162	36,204	35,883	33,973	27,252	26,291	25,818	25,695	21,243	-7,768	31,545	11,888	11,888	-12,199	6,909	3,750	3,748	3	3